期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 27, 期 5, 页码 235-237出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2006.03.010
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
Angiotensin II (Ang 11) has been implicated in the development of cardiovascular disorders and chronic kidney disease (CKD). Ang 11 causes renal lesions through the activation of tumor necrosis factor (TNF)-alpha-converting enzyme (TACE, also called a disintegrin and a metalloproteinase domain 17) and the release of transforming growth factor (TGF)-alpha, which binds to and activates the epidermal growth factor receptor. Renal lesions such as glomerulosclerosis, tubular atrophy, fibrosis, mononuclear cell infiltration and proteinuria following chronic Ang 11 infusion are substantially reduced in mice lacking TGF-alpha and those given a specific TACE inhibitor. These findings indicate that the selective inhibition of renal TACE could have therapeutic potential in the treatment of CKD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据